Transcatheter pulmonary valve implantation using the edwards SAPIEN™ transcatheter heart valve
Catheterization and Cardiovascular Interventions2009Vol. 75(2), pp. 286–294
Citations Over TimeTop 10% of 2009 papers
Robert Boone, John G. Webb, Eric Horlick, Lee Benson, Qi‐Ling Cao, Neha Nadeem, Marla Kiess, Ziyad M. Hijazi
Abstract
The SAPIEN THV can be used successfully in the treatment of patients with right ventricle to pulmonary artery homograft failure. The valve is durable to at least 3.5 years without stent fracture or regurgitation. Clinical trials are underway to assess the long-term safety and efficacy of this valve.
Related Papers
- → Right Ventricular Outflow Tract Reconstruction With a Polytetrafluoroethylene Monocusp Valve: A 20-Year Experience(2016)44 cited
- → Early results of Pulsta® transcatheter heart valve in patients with enlarged right ventricular outflow tract and severe pulmonary regurgitation due to transannular patch(2022)9 cited
- → Transcatheter perforation of the right ventricular outflow tract as initial therapy for pulmonary valve atresia and intact ventricular septum in the newborn(1997)6 cited
- Homologous monocuspid valve patch in right ventricular outflow tract reconstruction.(2001)
- → Percutaneous Melody™ Valve Implantation in Patients with Dysfunctional Right Ventricular Outflow Tract(2017)